Abstract:Sublancin is an antimicrobial peptide produced by Bacillus subtilis 168 containing 37 amino acids. The objective of this study was to investigate its inhibitory efficacy against Clostridium perfringens both in vitro and in vivo. In the in vitro study, we determined that sublancin had a minimum inhibitory concentration of 8 mu M against C. perfringens, which was much higher than the antibiotic lincomycin (0.281 mu M). Scanning electron microscopy showed that sublancin damaged the morphology of C. perfringens. The in vivo study was conducted on broilers for a 28-d period using a completely randomized design. A total of 252 chickens at 1 d of age were randomly assigned to 1 of 6 treatments including an uninfected control; an infected control; 3 infected groups supplemented with sublancin at 2.88, 5.76, or 11.52 mg activity/L of water; and an infected group supplemented with lincomycin at 75 mg activity/L of water (positive control). Necrotic enteritis was induced in the broilers by oral inoculation of C. perfringens on d 15 through 21. Thereafter, the sublancin or lincomycin were administered fresh daily for a period of 7 days. The C. perfringens challenge resulted in a significant decrease in ADG (P < 0.05) and a remarkable deterioration in G:F (P < 0.05) during d 15 to 21 of the experiment. There was a sharp increase of C. perfringens numbers in the cecum (P < 0.05). The addition of sublancin or lincomycin reduced caecal C. perfringens counts (P < 0.05). The Lactobacilli counts had a tendency to decrease in the lincomycin treatment (P = 0.051) but were the highest in the sublancin treatment (5.76 mg activity/L of water). A higher villus height to crypt depth ratio in the duodenum and jejunum as well as a higher villus height in the duodenum were observed in broilers treated with sublancin or lincomycin (P < 0.05) compared with infected control broilers. It was observed that sublancin and lincomycin decreased IL-1 beta, IL-6, and tumor necrosis factor-alpha levels (P < 0.05) in the ileum compared with the infected control. In conclusion, although sublancin's minimum inhibitory concentration is much higher than lincomycin in vitro, less sublancin is needed to control necrotic enteritis induced by C. perfringens in vivo than lincomycin. These novel findings indicate that sublancin could be used as a potential antimicrobial agent to control necrotic enteritis.

Enhancement of Macrophage Function by the Antimicrobial Peptide Sublancin Protects Mice from Methicillin-ResistantStaphylococcus Aureus

A Metabolite from Commensal Candida Albicans Enhances the Bactericidal Activity of Macrophages and Protects Against Sepsis

The bacteriocin sublancin attenuates intestinal injury in young mice infected with Staphylococcus aureus

Production of an attenuated phenol-soluble modulin variant unique to the MRSA clonal complex 30 increases severity of bloodstream infection.

Α-Mangostin Suppresses NLRP3 Inflammasome Activation Via Promoting Autophagy in LPS-stimulated Murine Macrophages and Protects Against CLP-induced Sepsis in Mice

The antimicrobial peptide sublancin ameliorates necrotic enteritis induced by in broilers.

Aberrant Expression of SLC7A11 Impairs the Antimicrobial Activities of Macrophages in Staphylococcus Aureus Osteomyelitis in Mice

Increased Susceptibility of S1PR3-Deficient Mice to Escherichia Coli Sepsis is Associated with an Impaired Bactericidal Activity in Macrophage

The attenuation of Th1 and Th17 responses via autophagy protects against methicillin-resistant <i>Staphylococcus aureus</i>-induced sepsis

Injectable Phage-Loaded Microparticles Effectively Release Phages to Kill Methicillin-Resistant <i>Staphylococcus aureus</i>

Methylsulfonylmethane protects against lethal dose MRSA-induced sepsis through promoting M2 macrophage polarization

A β-Lactamase Responsive Peptide Inhibits MRSA Infection through Self-Assembled Nanonet

Monoclonal Antibody Targeting Staphylococcus Aureus Surface Protein A (sasa) Protect Against Staphylococcus Aureus Sepsis and Peritonitis in Mice.

The combination of cloxacillin, thioridazine and tetracycline protects mice against Staphylococcus aureus peritonitis by inhibiting α-Hemolysin-induced MAPK/NF-κB/NLRP3 activation

Coating of a Novel Antimicrobial Nanoparticle with a Macrophage Membrane for the Selective Entry into Infected Macrophages and Killing of Intracellular Staphylococci

Quercetin Reduces the Virulence of S. aureus by Targeting ClpP to Protect Mice from MRSA-Induced Lethal Pneumonia

Microbiota-Derived Short-Chain Fatty Acids Promote LAMTOR2-Mediated Immune Responses in Macrophages

A purified membrane protein from Akkermansia muciniphila blunted the sepsis-induced acute lung injury by modulation of gut microbiota in rats

MIR-155 PROMOTES ACUTE ORGAN INJURY IN LPS-INDUCED ENDOTOXEMIC MICE BY ENHANCING CCL-2 EXPRESSION IN MACROPHAGES.

Scutellarin potentiates vancomycin against lethal pneumonia caused by methicillin-resistant Staphylococcus aureus through dual inhibition of sortase A and caseinolytic peptidase P

Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus